US agency selects UQ for ‘one of the world’s most ambitious biomanufacturing programs’

by rss feed | Oct 22, 2026 | News Feeds

A United States Government agency has selected University of Queensland researchers to develop technology for personalized RNA medicines to be produced in hospitals, allowing lifesaving treatments to reach patients within days. Read Original...

Zylidac Bio and Prolific Machines partner to scale Prolific’s next-generation biologics manufacturing platform to GMP production

by rss feed | Oct 22, 2026 | News Feeds

Zylidac Bio, a fully integrated biologics CDMO within the Zydus Lifesciences Limited (Zydus) group, and Prolific Machines, a biotechnology company advancing biologics development and manufacturing through integrated optogenetics-enabled solutions delivering...

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

by rss feed | Oct 22, 2026 | News Feeds

Discover expert insights into single-cell proteomics, revealing protein diversity and non-canonical biology with advanced mass spectrometry Read Original...

A simple facial photograph may hold clues to cancer survival

by rss feed | Oct 22, 2026 | News Feeds

FAHR-Face leverages AI to extract prognostic data from facial photographs, potentially transforming cancer survival predictions and clinical decision-making. Read Original...

Modus Therapeutics: SEVUSMART study of sevuparin in children with severe malaria published in Nature Communications

by rss feed | Oct 22, 2026 | News Feeds

Modus Therapeutics Holding AB (publ) announces that the manuscript based on the Phase Ib study SEVUSMART in severe malaria, lead-authored by Professor Kathryn Maitland of Imperial College London with co-authors from the SMAART consortium including members such as...